Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline.
Lenders JW, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SK, Murad MH, Naruse M, Pacak K, Young WF Jr; Endocrine Society.
J Clin Endocrinol Metab. 2014 Jun;99(6):1915-42. doi: 10.1210/jc.2014-1498.
Biochemical Assessment of Pheochromocytoma and Paraganglioma.
Eisenhofer G, Pamporaki C, Lenders JWM.
Endocr Rev. 2023 Sep 15;44(5):862-909. doi: 10.1210/endrev/bnad011.
Update on the diagnosis of the pheochromocytoma.
Achote E, Arroyo Ripoll OF, Araujo-Castro M.
Hipertens Riesgo Vasc. 2025 Jan-Mar;42(1):43-51. doi: 10.1016/j.hipert.2024.08.001. Epub 2024 Oct 10.
Pheochromocytoma and paraganglioma-an update on diagnosis, evaluation, and management.
Jain A, Baracco R, Kapur G.
Pediatr Nephrol. 2020 Apr;35(4):581-594. doi: 10.1007/s00467-018-4181-2. Epub 2019 Jan 2.
Phaeochromocytoma.
Cryer PE.
Clin Endocrinol Metab. 1985 Feb;14(1):203-20. doi: 10.1016/s0300-595x(85)80070-0.
[Spontaneous retroperitoneal hemorrhage].
Bjarnason J, Bazan Asencios LF, Thorisson HM, Reynisson KI.
Laeknabladid. 2023 Jun;109(6):292-295. doi: 10.17992/lbl.2023.05.744.
Androgens in Cushing's Syndrome.
Arnaldi G, Martino M.
Front Horm Res. 2019;53:77-91. doi: 10.1159/000494904. Epub 2019 Sep 9.
Diagnostic pitfalls of adrenal incidentaloma.
Cyrańska-Chyrek E, Grzymisławska M, Ruchała M.
Endokrynol Pol. 2017;68(3):360-377. doi: 10.5603/EP.2017.0028.
Subclinical Cushing's syndrome.
Reincke M.
Endocrinol Metab Clin North Am. 2000 Mar;29(1):43-56. doi: 10.1016/s0889-8529(05)70115-8.
[Pheochromocytoma].
Pereira MA, Souza BF, Freire DS, Lucon AM.
Arq Bras Endocrinol Metabol. 2004 Oct;48(5):751-75. doi: 10.1590/s0004-27302004000500022. Epub 2005 Mar 7.
